These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34042174)

  • 21. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J; Lee S
    Pharmacotherapy; 2018 Nov; 38(11):1095-1105. PubMed ID: 30225928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of statins on total cholesterol concentrations, cardiovascular morbidity, and all-cause mortality in chronic obstructive pulmonary disease: a population-based cohort study.
    Sheng X; Murphy MJ; MacDonald TM; Schembri S; Simpson W; Winter J; Winter JH; Wei L
    Clin Ther; 2012 Feb; 34(2):374-84. PubMed ID: 22244052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statins, risk of diabetes, and implications on outcomes in the general population.
    Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
    J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events-a cohort study in 395 039 patients from clinical practice.
    Motsko SP; Russmann S; Ming EE; Singh VP; Vendiola RM; Jones JK
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1214-22. PubMed ID: 19780020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular morbidity associated with nonadherence to statin therapy.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW
    Pharmacotherapy; 2005 Aug; 25(8):1035-43. PubMed ID: 16207093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
    Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
    Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk and renal transplantation: post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) Study.
    Jardine AG; Fellström B; Logan JO; Cole E; Nyberg G; Grönhagen-Riska C; Madsen S; Neumayer HH; Maes B; Ambühl P; Olsson AG; Pedersen T; Holdaas H
    Am J Kidney Dis; 2005 Sep; 46(3):529-36. PubMed ID: 16129216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early cardiovascular events and cardiovascular death after renal transplantation: role of pretransplant risk factors.
    De Lima JJG; Gowdak LHW; David-Neto E; Bortolotto LA
    Clin Exp Nephrol; 2021 May; 25(5):545-553. PubMed ID: 33506358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The beneficial effects of statins in patients undergoing hemodialysis.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chung CM; Huang PH; Lin SJ; Chen JW; Leu HB
    Int J Cardiol; 2013 Oct; 168(4):4155-9. PubMed ID: 23928338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
    Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statin dose titration patterns and subsequent major cardiovascular events in very high-risk patients: estimates from Swedish population-based registry data.
    Banefelt J; Lindh M; Svensson MK; Eliasson B; Tai MH
    Eur Heart J Qual Care Clin Outcomes; 2020 Oct; 6(4):323-331. PubMed ID: 32239140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery.
    Collard CD; Body SC; Shernan SK; Wang S; Mangano DT; ;
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):392-400. PubMed ID: 16872968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate-risk noncardiac, nonvascular surgery.
    Raju MG; Pachika A; Punnam SR; Gardiner JC; Shishehbor MH; Kapadia SR; Abela GS
    Clin Cardiol; 2013 Aug; 36(8):456-61. PubMed ID: 23670940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of statins on total cholesterol and cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis.
    Sheng X; Murphy MJ; Macdonald TM; Wei L
    J Rheumatol; 2012 Jan; 39(1):32-40. PubMed ID: 22045835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparative effectiveness of statin therapy in selected chronic diseases compared with the remaining population.
    Sheng X; Murphy MJ; MacDonald TM; Wei L
    BMC Public Health; 2012 Aug; 12():712. PubMed ID: 22935195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation.
    Streja E; Gosmanova EO; Molnar MZ; Soohoo M; Moradi H; Potukuchi PK; Kalantar-Zadeh K; Kovesdy CP
    JAMA Netw Open; 2018 Oct; 1(6):e182311. PubMed ID: 30646217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High plasma guanidinoacetate-to-homoarginine ratio is associated with high all-cause and cardiovascular mortality rate in adult renal transplant recipients.
    Hanff E; Said MY; Kayacelebi AA; Post A; Minovic I; van den Berg E; de Borst MH; van Goor H; Bakker SJL; Tsikas D
    Amino Acids; 2019 Nov; 51(10-12):1485-1499. PubMed ID: 31535220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative statin therapy is associated with a significant and dose-dependent reduction of adverse cardiovascular outcomes after coronary artery bypass graft surgery.
    Ouattara A; Benhaoua H; Le Manach Y; Mabrouk-Zerguini N; Itani O; Osman A; Landi M; Riou B; Coriat P
    J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):633-8. PubMed ID: 19362495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting and Non-Fasting Triglycerides and Risk of Cardiovascular Events in Diabetic Patients Under Statin Therapy.
    Tada H; Nomura A; Yoshimura K; Itoh H; Komuro I; Yamagishi M; Takamura M; Kawashiri MA
    Circ J; 2020 Feb; 84(3):509-515. PubMed ID: 32023582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.